FDA Inspection
UF Reproductive Medicine at SpringhillUF Reproductive Medicine at Springhill – FDA Inspection, Jul 18, 2011
Record Details
This FDA Inspection record concerns UF Reproductive Medicine at Springhill, with an inspection on July 18, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 18, 2011
- Product Type
- Biologics
View Company Profile
ID · 392d1f26-762e-4288-98fb-4dfedbd3a667
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 735060
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of UF Reproductive Medicine at Springhill
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2026 | Not classified | Florida District Office | |
| November 7, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 6, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 27, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for UF Reproductive Medicine at Springhill
- FDA Inspection 1303158 - 2026-02-09
- FDA Inspection 1191870 - 2022-11-07
- FDA Inspection 1092804 - 2019-06-06
- FDA Inspection 987875 - 2016-09-27
- FDA Inspection 895060 - 2014-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.